Redox Revolution
The FDA recently announced it will review the safety and efficacy of a number of powerful peptides. In 2023, based on safety concerns and reports that providers were treating patients irresponsibly, the FDA assigned a number of peptides for Category 2, effectively banning US pharmacies from compounding them. Today, Dr. Seeds addresses the why, the how, and the what’s next. Learn more about SSRP Institute [https://ssrpinstitute.org/] Follow for more! Instagram: @williamseedsmd [https://www.instagram.com/williamaseedsmd/] | @redoxmedicalgroup [https://www.instagram.com/redoxmedicalgroup/] Youtube: Subscribe Here [https://www.youtube.com/channel/UCqECEb71Ybc-kPtg7ITtuAw?sub_confirmation=1]
66 Episoder
Kommentarer
0Vær den første til å kommentere
Registrer deg nå og bli medlem av Redox Revolution sitt community!